India Markets open in 8 hrs 28 mins

Taro Pharmaceutical Industries Ltd. (TARO)


NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
115.22-0.94 (-0.81%)
As of 3:15PM EDT. Market open.
People also watch
LCISCRIIPXLUTHRPRGO
Full screen
Previous close116.16
Open116.24
Bid115.55 x 100
Ask115.99 x 300
Day's range115.22 - 116.76
52-week range92.28 - 148.00
Volume14,619
Avg. volume71,823
Market cap4.67B
Beta0.37
PE ratio (TTM)10.43
EPS (TTM)11.05
Earnings date8 Aug 2017 - 14 Aug 2017
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est100.00
Trade prices are not sourced from all markets
  • Capital Cube23 hours ago

    ETFs with exposure to Taro Pharmaceutical Industries Ltd. : June 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Taro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: Q4, 2017 By the Numbers : June 26, 2017
    Capital Cube2 days ago

    Taro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: Q4, 2017 By the Numbers : June 26, 2017

    Categories: Yahoo FinanceGet free summary analysis Taro Pharmaceutical Industries Ltd. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Taro Pharmaceutical Industries Ltd. – Mylan N.V., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, ... Read more (Read more...)

  • Business Wire6 days ago

    Taro Annual Report on Form 20-F Available for Fiscal Year Ended March 31, 2017

    Taro Pharmaceutical Industries Ltd. announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2017, filed with the Securities and Exchange Commission , is available within the Investor Relations section of Taro’s website at www.taro.com.